Stanford's AI designed 16 new viruses that kill resistant E. coli, demonstrating a significant leap in combating bacterial resistance. This development, alongside the discovery of 'ruptoblasts' for targeted cell destruction, highlights Stanford's rapid advancements in combating disease. Watch for further developments in clinical trials and biosafety protocols.